Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2022-07-21 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the schedule of an upcoming Analyst / Institutional Investors Meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of a meeting schedule, not a report or detailed financial document. The document length is only 1306 characters, indicating it is a brief announcement rather than a full report or transcript. Therefore, it fits best under the category of Investor Presentation (IP) or Regulatory Filings (RNS). However, since it is only a schedule notification and not the presentation itself, it is more appropriate to classify it as Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-07-21 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of an upcoming Analyst / Institutional Investors Meeting. It is a regulatory disclosure pursuant to SEBI regulations, providing dates and types of meetings but contains no financial data, analysis, or detailed presentation content. The document length is only 1304 characters, indicating it is a brief announcement rather than a full report or presentation. It does not contain financial statements or detailed investor presentation materials. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-19 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a notice for a Board Meeting. It mentions the notice was published in newspapers and is dated July 16, 2022. The content is brief (under 1,000 characters) and does not contain any financial data, results, or detailed reports. It is an announcement about the scheduling or publication of a Board Meeting notice rather than the meeting materials themselves or any financial or management report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-07-16 English
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for August 9, 2022, to consider and approve unaudited financial results for the quarter ended June 30, 2022. It also mentions the closure of the trading window in compliance with insider trading regulations. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a notice about the meeting and the forthcoming financial results, not the results or report itself. The document length is short (1361 characters), and it serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements and notices to exchanges.
2022-07-15 English
General updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (NSE and BSE) regarding Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It mentions enclosing a certificate from the Registrar and Share Transfer Agent for the quarter ended June 30, 2022. The document is short (1044 characters) and serves as an announcement or submission of a certificate rather than a full report. There is no financial data, management discussion, or detailed report content. This fits the category of a Regulatory Filing (RNS), as it is a compliance-related submission to the stock exchanges without substantive financial or operational data.
2022-07-07 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window in compliance with insider trading regulations. It references the upcoming declaration of unaudited financial results for the quarter ended June 30, 2022, but does not contain any financial data or results itself. The document is short (1157 characters) and serves as a regulatory announcement related to trading restrictions rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related notification.
2022-06-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.